VERILOGUE DEBUTS ON DELOITTE’S 2010 GREATER PHILADELPHIA FAST 50

HORSHAM, Pa. October 25, 2010 – Global pharmaceutical market research firm, Verilogue, receives Rising Star recognition in Deloitte’s Fast 50 Program for Greater Philadelphia in 2010. The Fast 50 ranking recognizes the fastest growing technology, media, telecommunications and life sciences companies in the area based on percentage revenue growth over a five year period. A…

VERILOGUE PRESENTS ON ELECTRONIC HEALTH RECORDS AND THE PHYSICIAN-PATIENT RELATIONSHIP AT PMRG

HORSHAM, Pa. October 22, 2010 – Verilogue, a leading pharmaceutical market research firm that captures and analyzes authentic physician-patient interactions, will examine the current and future influence of EHR [Electronic Health Record] on the doctor-patient dialogue. Specifically, Verilogue’s case study presentation at the Pharmaceutical Market Research Group (PMRG) Institute in Boston later this month will…

VERILOGUE DISHES OUT FOR RETURNING PENNSYLVANIA TROOPS

HORSHAM, Pa. – October 8, 2010 – Following a period of rapid growth and commercial success in an overall sluggish economy, healthcare market research firm Verilogue donated a day of community service to welcome home Pennsylvania troops returning from tours overseas. Under the guidance of Normandy Farms’ experienced chefs, Verilogue team members prepared entrees and notes…

VERILOGUE ACHIEVES RECORD GROWTH IN FIRST HALF OF 2010

HORSHAM, Pa. – June 29, 2010 – The first health care market research company to listen to, analyze and deliver nationwide insights derived from naturally-occurring dialogue between patients and physicians,Verilogue today announced it has captured more than 50,000 physician-patient conversations across the continuum of care, from routine well visits to the heartfelt delivery of metastatic…

MEDAD NEWS: UNSCRIPTED SCRUTINY

The battle for the hearts, minds and prescription pads of physi-cians treating targeted patients has always been challenging,but competitive pressures have never been more intense.Impending patent expirations threaten to expose billions of dollars in branded products to generic erosion. Mounting regulatory pressures,a feverish political climate and lukewarm economic conditions place even greater restrictions on how…

PHARMAEXEC: TALK OF THE TOWN

REMS programs. Megamergers. Generic encroachment. New sampling guidelines. The “unknowns” in the pharma industry have never been more prevalent or complex. But despite volumes of lagging prescription data and recall-based market research, pharma is still struggling to understand and anticipate how each new industry issue will impact current and future success. The key to understanding…

MEDAD NEWS: AD-VENTURES IN MARKETING

This past September, Med Ad News be- gan its now-annual search for the future of pharmaceutical marketing. We sought out young companies to profile that are provid- ing the most innovative and interesting prod- ucts, services, or marketing opportunities to pharmaceutical companies and the healthcare community. After reviewing dozens of nomi- nations, many of which…

SALES FORCE REPORT: THE ONLINE REP

Just a few short years ago most doctors were technophobic.You would have been hard-pressed to get an physican to consider electronic prescribing or logging-on to web-based medical conference. What a difference a few years can make. According to Manhattan Research, in 2009 ,87% of US physicians are considered “ePharma” physicians. In others words , they…

MEDADNEWS: CLINIC-SPECIFIC WEBSITES ON THE RISE

In the upcoming November issue of Med Ad News, our sales-force effectiveness series continues with a technology round up, providing a catalogue of new and upgraded tech solutions for pharma sales forces. But technology is not only connecting healthcare professionals with pharmaceutical marketers. Physicians are connecting with their patients through digital channels as well. According…